Direct-to-consumer genetic testing (DTC GT) is a convenient and increasingly popular method to help people obtain genetic information. Primary care and specialty healthcare professionals encounter patients with questions regarding DTC GT results, but may be reluctant to tackle genomic medicine in their clinical practice and are seeking opportunities to enhance their genomic knowledge. This course will help PAs apply knowledge of DTC GT results and develop the skills to manage patient cases that include carrier testing, low, moderate and high-risk health and disease risks, and pharmacogenomic results. This course will be run by genetics professionals who are members of the Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG)/NIH, which aims to improve genomic literacy of healthcare professionals and enhance the effective practice of clinical genomic medicine. This group has designed this course as part of the DTC GT project.

Learning Objectives

At the conclusion of this session, participants should be able to:

• Describe the current direct-to-consumer (DTC) genetic/genomic testing (GT) landscape
• Assess DTC GT disease risk results in a patient scenario
• Apply DTC GT carrier results in a patient scenario
• Evaluate DTC GT pharmacogenomic results in a patient scenario